Achieve Life Sciences, Inc. · NASDAQ:ACHV
Paradigm Biocapital Advisors LP reported a 9.20% stake in Achieve Life Sciences, Inc. (Schedule 13G)
Event Apr 17, 2026 · Filed Apr 24, 2026
Paradigm Biocapital Advisors LP reported a 9.20% stake in Achieve Life Sciences, Inc., 9,903,712 shares, as a passive investor on Apr 17, 2026. Filed Apr 24, 2026 (Schedule 13G).
- Stake
- 9.20%
- Shares
- 9,903,712
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 9.20% | 9,903,712 |
| Paradigm BioCapital Advisors GP LLC | 9.20% | 9,903,712 |
| Senai Asefaw, M.D. | 9.20% | 9,903,712 |
| Paradigm BioCapital International Fund Ltd. | 8.10% | 8,687,536 |
Source
Related
- Achieve Life Sciences, Inc.
- Paradigm Biocapital Advisors LP
- Achieve Life Sciences, Inc. shareholders
- Form 4 · Stewart Richard Alistair · Aug 21, 2026
- Schedule 13G · Logos Global Management LP · Aug 17, 2026
- Schedule 13G · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Franklin Resources Inc · Jul 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026